- Filed
- May 15, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · May 15, 2025 | 14.92M sh |
| Cash And Equivalents | Q1 2025 · Mar 31, 2025 | $1.29M |
| Cash And Equivalents | Q1 2025 · Dec 31, 2024 | $81K |
| Current Liabilities | Q1 2025 · Mar 31, 2025 | $65M |
| Current Liabilities | Q1 2025 · Dec 31, 2024 | $63.9M |
| Total Liabilities | Q1 2025 · Mar 31, 2025 | $70.38M |
| Total Liabilities | Q1 2025 · Dec 31, 2024 | $68.93M |
| Current Assets | Q1 2025 · Mar 31, 2025 | $50.45M |
| Current Assets | Q1 2025 · Dec 31, 2024 | $44.76M |
| Total Assets | Q1 2025 · Mar 31, 2025 | $105.58M |
| Total Assets | Q1 2025 · Dec 31, 2024 | $101.9M |
| Operating Cash Flow | Q1 2025 · Mar 31, 2024 | −$6.25M |
| Stockholders Equity | Q1 2025 · Mar 31, 2024 | $48.22M |
| Stockholders Equity | Q1 2025 · Dec 31, 2023 | $41.6M |
| Eps Diluted | Q1 2025 · Mar 31, 2024 | $0.44 |
| Eps Basic | Q1 2025 · Mar 31, 2024 | $0.44 |
| Sga Expense | Q1 2025 · Mar 31, 2024 | $983K |
| Net Income | Q1 2025 · Mar 31, 2024 | $6.62M |
| Operating Income | Q1 2025 · Mar 31, 2024 | $9.83M |
| Cost Of Revenue restated | Q1 2025 · Mar 31, 2024 | $79.83M |
| Revenue | Q1 2025 · Mar 31, 2024 | $91.02M |